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methods	 towards	 their	 synthesis	 frequently	 rely	 on	 the	 use	 of	 dipolar	 aprotic	 solvents;	 however,	 due	 to	 increasingly	
stringent	 regulations	 and	 growing	 societal	 pressures,	 safe	 and	 more	 sustainable	 alternatives	 are	 highly	 sought	 after.	





The	 amide	 functionality	 is	 ubiquitous	 throughout	 the	
natural	world,	forming	the	backbone	of	essential	biomolecules	
(e.g.	 proteins)	 as	 well	 as	 many	 widely	 used	 materials	 (e.g.	
polyamides).
1,2
	 Additionally,	 the	 amide	 moiety	 has	 profound	
importance	 to	 modern	 pharmaceutical	 development.	 This	 is	
clearly	 demonstrated	 throughout	 the	 chemical	 literature,	
where	amide	bond	formation	is	consistently	highlighted	as	the	
most	 frequently	 performed	 transformation	 in	 medicinal	
chemistry.
3-5
	 Indeed,	 Brown’s	 recent	 analysis	 of	 past	 and	
present	 synthetic	 methodologies	 within	 medicinal	 chemistry	
revealed	 that	 50%	of	manuscripts	 surveyed	 (a	 representative	
data	 set	 of	 125	 papers	 taken	 from	 J.	 Med.	 Chem.	 in	 2014)	
contained	the	transformation	in	the	context	of	small	molecule	
synthesis.	 The	 authors	 also	 note	 that	 the	 amide	 functionality	
occurs	 in	>50%	of	pharmaceutical	drug	discovery	patents	and	
journals	 (as	 calculated	 by	 the	 IBEX	 database).
3
	 In	 addition	 to	
these	 significant	 statistics	within	 small	molecule	 drug	 design,	
the	number	of	peptides	being	approved	for	therapeutic	use	is	
growing	 dramatically.	 Analysis	 of	 the	 peptide	 drug	 market	
carried	out	by	Nuss	 revealed	 that,	as	of	2016,	 the	number	of	
peptides	approved	as	drugs	was	56	while	a	 further	178	were	
involved	 in	 clinical	 trials	 (Phase	 I-III).
6










	 and	 commonly	 rely	 on	 the	 use	 of	
dipolar	aprotic	solvents,	the	continued	use	of	which	is	of	great	
concern	 due	 to	 the	 safety	 issues	 they	 pose.	 Exposure	 to	
solvents	such	as	DMF	and	NMP	is	associated	with	reproductive	






In	 this	 respect,	 solvent	selection	and	more	specifically	 the	
reduction	in	usage	of	dipolar	aprotic	solvents	such	as	DMF	and	




number	 of	 tools	 and	 guides	 have	 been	 published	 to	 allow	
chemists	to	identify	suitable	alternatives	and	make	changes	to	













previously	 evaluated	 the	 use	 of	 selected	 alternative	 solvents	
within	 four	 benchmark	 amide	 bond	 forming	 reactions,	




papers	 have	 been	 published	 detailing	 the	 replacement	 of	
dipolar	 aprotic	 solvents	 within	 solid	 phase	 peptide	 synthesis	
(SPPS).
20-24
	 In	 addition	 to	 these	 important	 contributions,	
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In	 addition	 to	 the	 safety	 aspects	 surrounding	 the	 use	 of	
conventional	 solvents,	 growing	 societal	 and	 political	 pressure	
towards	 the	 greening	 of	 chemical	 industries	 places	 emphasis	
on	 the	 reduction	 of	 petroleum	 based	 chemicals	 in	 favour	 of	
those	 derived	 from	 sustainable	 sources.
26
	 To	 address	 this	
movement,	many	Green	Chemistry	initiatives	within	academia	






1),	 which	 can	 be	 accessed	 from	 cellulose	 in	 two	 steps,	 has	
been	shown	to	possess	similar	physical	properties	to	DMF	and	
other	 dipolar	 aprotic	 solvents	 and	 is	 not	 currently	 associated	
with	 any	 harmful	 effects.
34-40
	 Cyrene	 has	 previously	
demonstrated	 successful	 application	 in	 materials	
chemistry,
41,42
	 in	 addition	 to	 synthetic	 organic	
transformations.
43-45







formation	 we	 selected	 N-[(dimethylamino)-1H-1,2,3-triazolo-[4,5-
b]pyridin-	 1-ylmethylene]-	 N-methyl-	 methanaminium	



























(1.2	 equiv.,	 0.3	 mmol).	
b	
%	 conversion	 calculated	 by	
1
H	 NMR	 using	 1,4-








of	 3a	 were	 recorded	 further	 repetitions	 failed	 to	 deliver	
consistency.	We	found	that	this	was	due	to	variable	stirring	rate	and	
as	 such,	 stringent	 control	 of	 this	 factor	 allowed	 us	 to	 establish	
consistency	(Entry	3).	Upon	increasing	the	stirring	rate	higher	yields	
with	 little	 variance	 could	 be	 achieved	 (Entry	 3-5).	 	 Cyrene	 is	 a	
viscous	liquid,	which	we	believe	gives	rise	to	sub-optimal	mixing	at	






amines	 (Scheme	 1).	 Variation	 of	 the	 carboxylic	 acid	 and	 amine	
components	 was	 broadly	 successful	 (15	 examples,	 63-100%)	 with	
alkyl	 (e.g.,	3g,	3j)	and	aryl	 (e.g.,	3k,	3m)	moieties	of	both	coupling	
partners	 tolerated.	 In	 addition	 to	 primary	 amines	 we	 found	 that	
both	cyclic	(e.g.,	3c,	3i)	and	acyclic	(e.g.,	3f)	secondary	amines	could	





Scheme	 1.	 HATU	 mediated	 amide	 bond	 formation:	 Scope	 of	 the	 transformation.	
Isolated	yields.	Acid	(1	equiv.,	0.25	mmol),	amine	(1.1	equiv.,	0.275	mmol),	HATU	(1.2	
equiv.,	0.3	mmol),	DIPEA	(3	equiv.,	0.75	mmol),	Cyrene	(1.25	mL,	0.2	M),	rt,	1	h.	
We	 next	 applied	 these	 conditions	 in	 the	 synthesis	 of	
peptides	 (Scheme	 2).	 Again,	 high	 yields	 are	 reported	 in	 the	
coupling	 of	 protected	 amino	 acids,	 with	 a	 broad	 scope	 of	
functionality	demonstrated	(9	examples,	63-100%).	In	addition	
to	 amino	 acids	 whose	 side	 chains	 bore	 alkyl	 and	 aryl	







examples	 (6b,	6d,	 and	6h)	we	 found	 it	 necessary	 to	 increase	
the	equivalents	of	HATU	to	improve	the	yield.		
These	 conditions	 could	 also	 be	 applied	 to	 the	 gram-scale	
synthesis	 of	 6c.	 Following	 a	 series	 of	 aqueous	 washes	 and	
trituration	with	cold	diethyl	ether	to	ensure	complete	removal	
of	 Cyrene	 (See	 ESI	 for	 full	 work-up	 procedure),	 analytically	
pure	product	could	be	isolated	in	quantitative	yield.	
Scheme	 2	 HATU	 mediated	 amide	 bond	 formation:	 Scope	 of	 the	 coupling	 of	 amino	







mediated	 amide	 bond	 formation	 as	 a	 direct	 alternative	 to	
conventional	 solvents	 (DMF,	NMP).	The	conditions	developed	
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